
President of @FightCRC. Passionate about community engagement, patient empowerment, and social good. #crcadvocacy #CancerSurvivor 💪🏽 #RelentlessChampions
Joined December 2011
- Tweets8.4K
- Following1.1K
- Followers1.9K
- Likes18.8K
Pinned Tweet
Cancer research is not a line item. It’s a lifeline. 🔬
@ZEROcancer, @FightCRC, @LUNGevity, @PanCAN, @AACI_Cancer + @SusanGKomen join forces to urge sustained federal funding that fuels progress + saves lives.
Read the special co-authored Commentary 🔗 conta.cc/3HRf2ab
AnjeeDavis retweeted
We're rallying 500 climbers across the country to show that #NoOneClimbsAlone.
So let's do this together.
You can join from anywhere:
✔️ Stairs
✔️ Trails
✔️ Treadmills
✔️ Neighborhood walks
Register for #ClimbForACure before July 1: fightcrc.org/climb
AnjeeDavis retweeted
Our #ClinicalTrials Newsletter delivers the latest #colorectalcancer updates, expert insights, & clinical trial highlights straight to your inbox—explore the information that matters most to you, all in one place 📫
Thank you to our sponsors 💙: @Merck @JNJNews @bmsnews @SMMT_TX
AnjeeDavis retweeted
Turn your story into action. 📣 Join our upcoming Advocacy Action Hour on July 16 at 8:30 PM ET to learn how to work with local media, write a media pitch, and amplify your advocacy beyond social media.
Register now: fightcrc.org/actionhr
Don't let Congress Leave CRC Research Behind! votervoice.net/Shares/BAAAAA…
AnjeeDavis retweeted
500 climbers needed nationwide by July 1.
Join #climbforacure from anywhere:
💪 Free to join
💪 No travel required
💪 Climb your way
💪 Raise $250 for research
Stairs. Hills. Trails. Treadmills. Your climb counts.
fightcrc.org/climb
I just donated to @FightCRC ! my goal is to rally an additional $250!!! Will you join me in supporting our team! secure.qgiv.com/event/2026cl…
AnjeeDavis retweeted
Tomorrow at 1 PM ET: Fight CRC's Research Highlights from @ASCO webinar.
Join @ChrisCannMD of @FoxChaseCancer & @ARosen380 for a discussion of promising #clinicaltrial results, advances in precision medicine, & emerging #CRC research.
Register now: fightcrc.org/webinars
AnjeeDavis retweeted
New research. New possibilities. 💪
We've rounded up the most important #colorectalcancer findings from #ASCO2026 and what they could mean for patients, survivors, and caregivers.
Read the recap: fightcolorectalcancer.org/as…
@ASCO
AnjeeDavis retweeted
Always great to listen to @KimmieNgMD She discussed the Coming Wave of Early-Onset Cancer. With it on the rise we need to do more for these patients. A dedicated program can help with coordination of supportive care service like fertility preservation! @ASCO #ASCO26 @FightCRC
AnjeeDavis retweeted
We need 500 climbers by July 1.
#Climbforacure is going nationwide, and you can join from anywhere.
Free to join. No travel required. Climb your way.
Register today: fightcrc.org/climb
AnjeeDavis retweeted
Come talk to me about patient-reported outcomes! See results of PROs in the ATOMIC A021502 trial - Atezolizumab+mFOLFOX6 vs mFOLFOX6 for adjuvant colon cancer. #ASCO26 @ALLIANCE_org
AnjeeDavis retweeted
We all need to do more to incorporate structured exercise program as an affordable & available option to #CRC patients. Thank you for all your work! @CDNCancerTrials Dr. Chris Booth @GillSharlene #ASCO26 #CHALLENGE #CRCSM
#ASCO26 @ASCO
Cost-utility analysis of #CHALLENGE trial of structured #exercise (SEP) after ACT for stage 2-3 colon cancer @CDNCancerTrials 🇨🇦
📌SEP improves DFS & OS
➡️ SEP is less costly & more effective ‘Win-Win’ ✅
‼️We need to implement SEP into routine care 💪 #NoExcuses
@JCO_ASCO
🔗 ascopubs.org/doi/10.1200/JCO…
So proud of @JJSingleton1 for always bravely and authentically sharing his story to ground us that the science represents real lives (people we love) 💪🏽💙💪🏽 @fightcrc @ColonCancerCoal @StupidCancer #asco26
AnjeeDavis retweeted
#ASCO26 Abs LBA #3508: EPISODE-III (JCOG 1503C) randomizes ONLY stage III #coloncancer pts to ASA 100 mg x 3 yrs vs. placebo post adjuvant chemo. Primary endpoint = DFS. #cancer #cancerresearch @OncoAlert
Differs vs. ALASCAA trial (Martling et al; NEJM, 2025)
EPISODE-III
👉Stage III colon
👉PIK3CA MT was not required (PIK3CA MT analysis is ongoing)
👉Adjuvant therapy was required
🛑 In unselected patients, ASA 100 mg was not beneficial for DFS
AnjeeDavis retweeted
Kicking off the day at @ASCO with a talk discussing the role of ctDNA across the spectrum of cancer care from early detection to treatment by Valsamo Anagnostou of @HopkinsKimmel!
#ASCO26 #FightCRCRats #cancer @OncoAlert
AnjeeDavis retweeted
🚨HOT TOPIC: Multicancer Early Detection: Potential Versus Proof results by Mark Robson MD @MSKCancerCenter.
As an advocate do I tell patients to ask for it based on these results? Thoughts are welcome! #CRCTwitter #GITwitter #ASCO26 #FightCRCRats
@ASCO @FightCRC @OncoAlert
Thank you so much to the @ColonCancerCoal for their steadfast commitment to collaboration and fighting this disease together 💙 appreciate you so much!!! @EKPPRMPLS and Chris Evans 💙 #strongertogether @fightcrc
AnjeeDavis retweeted
#ASCO26: LBA #3501- Optimal duration of #adjuvant #chemotherapy (ACT) in resected stage I-IV #colorectal #cancer: Galaxy Japan #ctDNA dynamics.
👉No benefit from continuing ACT if neg
👉 Also suggests no benefit to continue > 3M if neg
👉Rise in ctDNA at 3M suggests do NOT continue
👉For my practice, the role of #ctDNA dynamics will be CONSIDERED as an additional tool during ACT. @asco @OncoAlert



































